Mark For: A2 BIOTHERAPEUTICS™ trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 88302588 |
Mark Literal Elements | A2 BIOTHERAPEUTICS |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | TRADEMARK. SERVICE MARK |
Register | PRINCIPAL |
Current Location | INTENT TO USE SECTION 2020-02-11 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Joi A. White |
Attorney Docket Number | T-4336 US |
Law Office Assigned | L40 |
Employee Name | CHADAB, SETH WILLIG |
2019-02-14 | Application Filed |
2019-04-25 | Location: TMEG LAW OFFICE 104 |
2019-04-25 | Status: Live/Pending |
2019-04-25 | Transaction Date |
2019-12-17 | Published |
2019-12-17 | Published for Opposition |
2019-12-18 | Trademark Registered |
2020-02-11 | Location: INTENT TO USE SECTION |
2020-07-20 | Status: A first request for extension of time to file a Statement of Use has been granted. |
Party: | A2 Biotherapeutics, Inc. |
Address | 30301 Agoura Road, Suite 210 Agoura Hills, CALIFORNIA UNITED STATES 91301 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
Drawing | JPEG | 2019-02-14 |
TEAS RF New Application | MULTI | 2019-02-14 |
Offc Action Outgoing | MULTI | 2019-05-02 |
XSearch Search Summary | XML | 2019-05-02 |
Response to Office Action | APPLICATION/XML | 2019-11-01 |
Amendment and Mail Process Complete | MULTI | 2019-11-05 |
TRAM Snapshot of App at Pub for Oppostn | APPLICATION/XML,IMAGE/JPEG | 2019-11-13 |
Notice of Publication | XML | 2019-11-27 |
Notification Of Notice of Publication | XML | 2019-11-27 |
OG Publication Confirmation | XML | 2019-12-17 |
Notice of Allowance | XML | 2020-02-11 |
Extension of Time to File SOU | APPLICATION/XML | 2020-07-20 |
ITU Extension Approval | APPLICATION/XML | 2020-07-22 |
ITU Unit Action | APPLICATION/XML,IMAGE/JPEG | 2020-07-22 |
IC 005. US 006 018 044 046 051 052. G & S: T-cell pharmaceutical products for the treatment of cancer; therapeutic targets, namely, proteins or protein complexes, for the treatment and prevention of cancer; therapeutic cells, for medical use, for the treatment and prevention of cancer; therapeutic proteins and therapeutic antibodies, for medical use, for the treatment and prevention of cancer in humans; therapeutics and cellular therapies in the nature of proteins and protein complexes for the treatment of cancer; biologics, namely, proteins and protein complexes for in-vitro diagnostic use for the treatment of cancer
IC 042. US 100 101. G & S: Provision of, and identification and development of, therapeutic targets, namely, proteins and protein complexes, for others for the treatment and prevention of cancer; development of therapeutics and cellular therapies, namely, pharmaceutical, biological and medical therapies for the treatment of cancer; biotechnology research, development, testing and analysis for the treatment of cancer; Scientific research and development services; providing scientific information in the fields of treatment and prevention of cancer
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0051 | T-cell pharmaceutical products for the treatment of cancer and inflammatory diseases; therapeutic targets for the treatment and prevention of cancer, inflammation and inflammatory diseases; therapeutic cells, therapeutic proteins and therapeutic antibodies for human use for the treatment and prevention of cancer, inflammation and inflammatory diseases; therapeutics and cellular therapies for the treatment of cancer, inflammation, and inflammatory diseases; biologics for in-vitro diagnostic use |
PM0001 | A TWO BIO THERAPEUTICS |
Description | Date | Proceeding Number |
---|---|---|
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-07-22 | |
TEAS EXTENSION RECEIVED | 2020-07-20 | |
EXTENSION 1 GRANTED | 2020-07-20 | 98765 |
EXTENSION 1 FILED | 2020-07-20 | 98765 |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2020-02-11 | |
PUBLISHED FOR OPPOSITION | 2019-12-17 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-12-17 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-11-27 | |
ASSIGNED TO LIE | 2019-11-14 | 70138 |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-11-12 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-11-02 | 88889 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-11-01 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-11-01 | 88889 |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-05-02 | 6325 |
NON-FINAL ACTION WRITTEN | 2019-05-02 | 92449 |
NON-FINAL ACTION E-MAILED | 2019-05-02 | 6325 |
ASSIGNED TO EXAMINER | 2019-04-25 | 92449 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-03-08 | |
NEW APPLICATION ENTERED IN TRAM | 2019-02-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.